Kate Cunningham

Company: Personalis

Job title: Applications Scientist

Seminars:

Ultra-Sensitive MRD Utilization to Overcome Challenges in Early-Stage Cancer Recurrence Detection 3:00 pm

NeXT Personal is an advanced tumor-informed liquid biopsy assay with ultra-sensitive detection down to 1PPM Ultrasensitive detection with this bespoke whole genome sequencing based assay improves detection of ctDNA at baseline and during follow-up with increased lead time over clinical relapse Clinical studies in early-stage lung and breast cancer establish that NeXT Personal MRD detection…Read more

day: Day One Track B (1)